Tapewire

Nasdaq · USD

INVA

Innoviva, Inc.

Export transactions ↓
Tapewire entity
4679
SEC CIK
0001080014
Parsed reports
215

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 20, 2017 Filed May 23, 2017 20:16 UTC
Witek Theodore J. Jr.Sr. VP & Chief Scientific Off.
Tax withholdingCommon Stock 2,590 $11.86 $30,717.40
Disclosure

SEC source: 0001179110-17-007836 · edgar.xml · nonDerivative · entry 1

Witek Theodore J. Jr. · CIK 0001612452 · Sr. VP & Chief Scientific Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,968

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
May 20, 2017 Filed May 23, 2017 20:15 UTC
ABERCROMBIE GEORGE BSr. VP & Chief Comm. Officer
Tax withholdingCommon Stock 2,228 $11.86 $26,424.08
Disclosure

SEC source: 0001179110-17-007831 · edgar.xml · nonDerivative · entry 1

ABERCROMBIE GEORGE B · CIK 0001485939 · Sr. VP & Chief Comm. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,110

F1 · shares: These shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

F2 · balance_after: Includes 2,500 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2017.

Read SEC document
May 20, 2017 Filed May 23, 2017 20:15 UTC
dEsparbes EricSVP and CFO
Tax withholdingCommon Stock 4,208 $11.86 $49,906.88
Disclosure

SEC source: 0001179110-17-007830 · edgar.xml · nonDerivative · entry 1

dEsparbes Eric · CIK 0001622268 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,588

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
May 20, 2017 Filed May 23, 2017 20:14 UTC
Aguiar Michael WDirector · President & Chief Exec Officer
Tax withholdingCommon Stock 12,897 $11.86 $152,958.42
Disclosure

SEC source: 0001179110-17-007829 · edgar.xml · nonDerivative · entry 1

Aguiar Michael W · CIK 0001318005 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,048,884

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

F2 · balance_after: Includes 2,500 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on May 15, 2017.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 21:24 UTC GrantCommon Stock 19,857 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006175 · edgar.xml · nonDerivative · entry 1

FRIEDMAN CATHY · CIK 0001411874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,805

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 21:07 UTC GrantCommon Stock 19,857 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006173 · edgar.xml · nonDerivative · entry 1

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,318

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 21:06 UTC GrantCommon Stock 19,857 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006171 · edgar.xml · nonDerivative · entry 1

LEPORE PATRICK G · CIK 0001055404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,278

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 21:05 UTC GrantCommon Stock 19,857 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006170 · edgar.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,554

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 21:05 UTC GrantCommon Stock 19,857 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006169 · edgar.xml · nonDerivative · entry 1

WALTRIP WILLIAM H · CIK 0001188743 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,789

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.

Read SEC document
April 20, 2017 Filed Apr 24, 2017 21:04 UTC
PEPE PAULDirector
GrantCommon Stock 19,857 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006168 · edgar.xml · nonDerivative · entry 1

PEPE PAUL · CIK 0001607932 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,805

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"). 100% of the RSUs will vest at the sooner of the next annual shareholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.

Read SEC document
February 21, 2017 Filed Feb 22, 2017 21:30 UTC
dEsparbes EricSVP and CFO
SaleCommon Stock 1,825 $12.07 $22,027.75
Disclosure

SEC source: 0001179110-17-002898 · edgar.xml · nonDerivative · entry 2

dEsparbes Eric · CIK 0001622268 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,296

F2 · shares: This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016.

Read SEC document
February 20, 2017 Filed Feb 22, 2017 21:31 UTC
Aguiar Michael WDirector · President & Chief Exec Officer
Tax withholdingCommon Stock 19,429 $12.04 $233,925.16
Disclosure

SEC source: 0001179110-17-002900 · edgar.xml · nonDerivative · entry 1

Aguiar Michael W · CIK 0001318005 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,059,281

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
February 20, 2017 Filed Feb 22, 2017 21:31 UTC
ABERCROMBIE GEORGE BSr. VP & Chief Comm. Officer
Tax withholdingCommon Stock 5,355 $12.04 $64,474.20
Disclosure

SEC source: 0001179110-17-002899 · edgar.xml · nonDerivative · entry 1

ABERCROMBIE GEORGE B · CIK 0001485939 · Sr. VP & Chief Comm. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,838

F1 · shares: These shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
February 20, 2017 Filed Feb 22, 2017 21:30 UTC
dEsparbes EricSVP and CFO
Tax withholdingCommon Stock 8,604 $12.04 $103,592.16
Disclosure

SEC source: 0001179110-17-002898 · edgar.xml · nonDerivative · entry 1

dEsparbes Eric · CIK 0001622268 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 356,121

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
February 20, 2017 Filed Feb 22, 2017 21:29 UTC
Faerm Michael E.Sr VP & Chief Business Officer
Tax withholdingCommon Stock 5,860 $12.04 $70,554.40
Disclosure

SEC source: 0001179110-17-002897 · edgar.xml · nonDerivative · entry 1

Faerm Michael E. · CIK 0001647141 · Sr VP & Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,747

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
February 20, 2017 Filed Feb 22, 2017 21:28 UTC
Witek Theodore J. Jr.Sr. VP & Chief Scientific Off.
Tax withholdingCommon Stock 6,367 $12.04 $76,658.68
Disclosure

SEC source: 0001179110-17-002896 · edgar.xml · nonDerivative · entry 1

Witek Theodore J. Jr. · CIK 0001612452 · Sr. VP & Chief Scientific Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,782

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
January 17, 2017 Filed Jan 20, 2017 01:41 UTC
Faerm Michael E.Sr VP & Chief Business Officer
GrantCommon Stock 133,398 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-001096 · edgar.xml · nonDerivative · entry 1

Faerm Michael E. · CIK 0001647141 · Sr VP & Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,607

F1 · shares: Includes 66,698 shares of common stock granted pursuant to a time-based restricted stock award (RSA). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2018, and 6.25% of the shares subject to the RSA shall vest quarterly thereafter on the Issuer's standard vesting dates until February 20, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

F2 · shares: Includes shares of common stock granted pursuant to a performance-based restricted stock award (PSA). The shares vest pursuant to the PSA over a two-year and three-year performance period upon, and subject to a formula related to, the Issuer's achievement of certain levels of relative total shareholder return (TSR). The "target" number of shares that may vest is 33,350 but the actual number of shares that may vest will range from 0 to 66,700 shares based on the Issuer's relative TSR over the performance periods. Subject to achievement of the performance-based vesting conditions, (i) two-thirds of the shares eligible to vest based on achievement for the two-year performance period will vest on February 20, 2019 and the remaining one-third of such shares will vest on February 20, 2020 and (ii) the share eligible to vest based on achievement for the three-year performance period will vest on February 20, 2020, in each case, (continued in Footnote 3)

F3 · shares: (continued from Footnote 2) provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Read SEC document
January 17, 2017 Filed Jan 20, 2017 01:22 UTC
dEsparbes EricSVP and CFO
GrantCommon Stock 133,398 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-001081 · edgar.xml · nonDerivative · entry 1

dEsparbes Eric · CIK 0001622268 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,725

F1 · shares: Includes 66,698 shares of common stock granted pursuant to a time-based restricted stock award (RSA). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2018, and 6.25% of the shares subject to the RSA shall vest quarterly thereafter on the Issuer's standard vesting dates until February 20, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

F2 · shares: Includes shares of common stock granted pursuant to a performance-based restricted stock award (PSA). The shares vest pursuant to the PSA over a two-year and three-year performance period upon, and subject to a formula related to, the Issuer's achievement of certain levels of relative total shareholder return (TSR). The "target" number of shares that may vest is 33,350 but the actual number of shares that may vest will range from 0 to 66,700 shares based on the Issuer's relative TSR over the performance periods. Subject to achievement of the performance-based vesting conditions, (i) two-thirds of the shares eligible to vest based on achievement for the two-year performance period will vest on February 20, 2019 and the remaining one-third of such shares will vest on February 20, 2020 and (ii) the share eligible to vest based on achievement for the three-year performance period will vest on February 20, 2020, in each case, (continued in Footnote 3)

F3 · shares: (continued from Footnote 2) provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Read SEC document
January 17, 2017 Filed Jan 20, 2017 01:27 UTC
Aguiar Michael WDirector · President & Chief Exec Officer
GrantCommon Stock 333,495 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-001091 · edgar.xml · nonDerivative · entry 1

Aguiar Michael W · CIK 0001318005 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,710

F1 · shares: Includes 166,747 shares of common stock granted pursuant to a time-based restricted stock award (RSA). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2018, and 6.25% of the shares subject to the RSA shall vest quarterly thereafter on the Issuer's standard vesting dates until February 20, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

F2 · shares: Includes shares of common stock granted pursuant to a performance-based restricted stock award (PSA). The shares vest pursuant to the PSA over a two-year and three-year performance period upon, and subject to a formula related to, the Issuer's achievement of certain levels of relative total shareholder return (TSR). The "target" number of shares that may vest is 83,374, but the actual number of shares that may vest will range from 0 to 166,748 shares based on the Issuer's relative TSR over the performance periods. Subject to achievement of the performance-based vesting conditions, (i) two-thirds of the shares eligible to vest based on achievement for the two-year performance period will vest on February 20, 2019 and the remaining one-third of such shares will vest on February 20, 2020 and (ii) the share eligible to vest based on achievement for the three-year performance period will vest on February 20, 2020, in each case, (continued in Footnote 3)

F3 · shares: (continued from Footnote 2) provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Read SEC document
January 17, 2017 Filed Jan 20, 2017 01:26 UTC
ABERCROMBIE GEORGE BSr. VP & Chief Comm. Officer
GrantCommon Stock 106,718 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-001087 · edgar.xml · nonDerivative · entry 1

ABERCROMBIE GEORGE B · CIK 0001485939 · Sr. VP & Chief Comm. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,193

F1 · shares: Includes 53,358 shares of common stock granted pursuant to a time-based restricted stock award (RSA). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2018, and 6.25% of the shares subject to the RSA shall vest quarterly thereafter on the Issuer's standard vesting dates until February 20, 2021, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

F2 · shares: Includes shares of common stock granted pursuant to a performance-based restricted stock award (PSA). The shares vest pursuant to the PSA over a two-year and three-year performance period upon, and subject to a formula related to, the Issuer's achievement of certain levels of relative total shareholder return (TSR). The "target" number of shares that may vest is 26,680, but the actual number of shares that may vest will range from 0 to 53,360 shares based on the Issuer's relative TSR over the performance periods. Subject to achievement of the performance-based vesting conditions, (i) two-thirds of the shares eligible to vest based on achievement for the two-year performance period will vest on February 20, 2019 and the remaining one-third of such shares will vest on February 20, 2020 and (ii) the share eligible to vest based on achievement for the three-year performance period will vest on February 20, 2020, in each case, (continued in Footnote 3)

F3 · shares: (continued from Footnote 2) provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Read SEC document
January 17, 2017 Filed Jan 20, 2017 01:22 UTC
Witek Theodore J. Jr.Sr. VP & Chief Scientific Off.
GrantCommon Stock 106,718 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-001080 · edgar.xml · nonDerivative · entry 1

WITEK THEODORE L JR · CIK 0001612452 · Sr. VP & Chief Scientific Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,149

F1 · shares: Includes 53,358 shares of common stock granted pursuant to a time-based restricted stock unit award (RSU). Twenty-five percent of the shares subject to the RSU shall vest on February 20, 2018, and 6.25% on May 20, 2018, 6.25% on August 20, 2018, 6.25% on November 20, 2018, 6.25% on February 20, 2019, 6.25% on May 20, 2019, 6.25% on August 20, 2019 and the remaining 37.5% on November 20, 2019, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

F2 · shares: Includes shares of common stock granted pursuant to a performance-based restricted stock unit award (PSU). The shares vest pursuant to the PSU over a two-year and 32-month performance period upon, and subject to a formula related to, the Issuer's achievement of certain levels of relative total shareholder return (TSR). The "target" number of shares that may vest is 26,680, but the actual number of shares that may vest will range from 0 to 53,360 shares based on the Issuer's relative TSR over the performance periods. Subject to achievement of the performance-based vesting conditions, (i) two-thirds of the shares eligible to vest based on achievement for the two-year performance period will vest on February 20, 2019 and the remaining one-third of such shares will vest on November 20, 2019 and (ii) the share eligible to vest based on achievement for the 32-month performance period will vest on November 20, 2019, in each case, (continued in Footnote 3)

F3 · shares: (continued from Footnote 2) provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Read SEC document
November 22, 2016 Filed Nov 22, 2016 22:40 UTC
Witek Theodore J. Jr.Sr. VP & Chief Scientific Off.
SaleCommon Stock 3,700 $10.84 $40,122.80
Disclosure

SEC source: 0001179110-16-031971 · edgar.xml · nonDerivative · entry 2

WITEK THEODORE L JR · CIK 0001612452 · Sr. VP & Chief Scientific Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,431

F2 · balance_after: Includes 701 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2016.

Read SEC document
November 21, 2016 Filed Nov 22, 2016 22:45 UTC
dEsparbes EricSVP and CFO
SaleCommon Stock 1,800 $10.89 $19,602.00
Disclosure

SEC source: 0001179110-16-031973 · edgar.xml · nonDerivative · entry 2

dEsparbes Eric · CIK 0001622268 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,327

F3 · shares: This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated May 20, 2016.

Read SEC document
November 20, 2016 Filed Nov 22, 2016 22:40 UTC
Witek Theodore J. Jr.Sr. VP & Chief Scientific Off.
Tax withholdingCommon Stock 1,487 $10.91 $16,223.17
Disclosure

SEC source: 0001179110-16-031971 · edgar.xml · nonDerivative · entry 1

WITEK THEODORE L JR · CIK 0001612452 · Sr. VP & Chief Scientific Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,131

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

Read SEC document
November 20, 2016 Filed Nov 22, 2016 22:45 UTC
dEsparbes EricSVP and CFO
Tax withholdingCommon Stock 3,832 $10.91 $41,807.12
Disclosure

SEC source: 0001179110-16-031973 · edgar.xml · nonDerivative · entry 1

dEsparbes Eric · CIK 0001622268 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,127

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

F2 · balance_after: Includes 766 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2016.

Read SEC document
November 20, 2016 Filed Nov 22, 2016 22:43 UTC
Faerm Michael E.Sr VP & Chief Business Officer
Tax withholdingCommon Stock 2,893 $10.91 $31,562.63
Disclosure

SEC source: 0001179110-16-031972 · edgar.xml · nonDerivative · entry 1

Faerm Michael E. · CIK 0001647141 · Sr VP & Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,209

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

F2 · balance_after: Includes 232 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2016.

Read SEC document
November 20, 2016 Filed Nov 22, 2016 22:39 UTC
ABERCROMBIE GEORGE BSr. VP & Chief Comm. Officer
Tax withholdingCommon Stock 1,273 $10.91 $13,888.43
Disclosure

SEC source: 0001179110-16-031970 · edgar.xml · nonDerivative · entry 1

ABERCROMBIE GEORGE B · CIK 0001485939 · Sr. VP & Chief Comm. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,475

F1 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

F2 · balance_after: Includes 285 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2016.

Read SEC document
November 20, 2016 Filed Nov 22, 2016 22:28 UTC
Aguiar Michael WDirector · President & Chief Exec Officer
Tax withholdingCommon Stock 8,417 $10.91 $91,829.47
Disclosure

SEC source: 0001179110-16-031969 · edgar.xml · nonDerivative · entry 2

Aguiar Michael W · CIK 0001318005 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 745,215

F2 · shares: The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.

F3 · balance_after: Includes 285 shares of common stock acquired under the Innoviva, Inc. Employee Stock Purchase Plan on November 15, 2016.

Read SEC document
November 18, 2016 Filed Nov 21, 2016 23:35 UTC GrantCommon Stock 32,461 $0.00 $0.00
Disclosure

SEC source: 0001179110-16-031911 · edgar.xml · nonDerivative · entry 1

Duncan Barbara Gayle · CIK 0001353128 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,461

Read SEC document
November 18, 2016 Filed Nov 22, 2016 22:28 UTC
Aguiar Michael WDirector · President & Chief Exec Officer
GrantCommon Stock 63,135 $0.00 $0.00
Disclosure

SEC source: 0001179110-16-031969 · edgar.xml · nonDerivative · entry 1

Aguiar Michael W · CIK 0001318005 · Director · President & Chief Exec Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 753,347

F1 · shares: These shares were granted to the reporting person on February 11, 2011 as part of a performance stock award that vests based on the achievement of certain performance conditions over a six-year timeframe from 2011 through December 31, 2016 and continued employment. On November 18, 2016, the performance conditions applicable to 63,135 shares were deemed achieved and such shares shall vest on November 20, 2017, subject to the reporting person's continued employment through such date.

Read SEC document
October 26, 2016 Filed Oct 27, 2016 22:31 UTC GrantCommon Stock 38,421 $0.00 $0.00
Disclosure

SEC source: 0001179110-16-030971 · edgar.xml · nonDerivative · entry 1

LEPORE PATRICK G · CIK 0001055404 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,421

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.